Explore
Trendline
Live Ventures Reports Q2 2026 Financial Results with Net Loss and Segment Shifts
Live Ventures Reports Q2 2026 Financial Results with Net Loss and Segment Shifts
Read More
Trendline
Live Ventures Reports Q2 FY2026 Financial Results Highlighting Net Loss and Segment Improvements
Live Ventures Reports Q2 FY2026 Financial Results Highlighting Net Loss and Segment Improvements
Read More
Trendline
Live Ventures Reports Q2 FY2026 Revenue Decline and Net Loss Amid Market Challenges
Live Ventures Reports Q2 FY2026 Revenue Decline and Net Loss Amid Market Challenges
Read More
Trendline
Dillard's Reports Strong First Quarter Earnings with Increased Sales Across Categories
Dillard's Reports Strong First Quarter Earnings with Increased Sales Across Categories
Read More
Trendline
TherapeuticsMD Reports First Quarter 2026 Financial Results
TherapeuticsMD Reports First Quarter 2026 Financial Results
Read More
Trendline
Live Ventures Reports Q2 2026 Financial Results with Net Loss
Live Ventures Reports Q2 2026 Financial Results with Net Loss
Read More
Trendline
Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results Indicating Continued Net Loss
Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results Indicating Continued Net Loss
Read More
Trendline
JD Sports Reports 2026 Financial Results with Mixed Sales Performance Across Regions
JD Sports Reports 2026 Financial Results with Mixed Sales Performance Across Regions
Read More
Trendline
Hain Celestial Reports Debt Reduction Amid Third Quarter Losses
Hain Celestial Reports Debt Reduction Amid Third Quarter Losses
Read More
Trendline
Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results with Net Loss
Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results with Net Loss
Read More
Trendline
Arisinfra Solutions Reports Tenfold Profit Increase, Turns Net Cash Positive
Arisinfra Solutions Reports Tenfold Profit Increase, Turns Net Cash Positive
Read More
Trendline
Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements
Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements
Read More